What is the Expert Analysis of Bio Decontamination Market?
According to the expert analysis "Bio Decontamination Market by Product (Equipment, Service, Consumables), Agent (Hydrogen Peroxide, Chlorine, Nitrogen, Peracetic Acid), Type (Room, Chamber), End User (Pharma, Biotech, Medical Devices, Hospital, Life Science) - Global Forecast to 2024", published by MarketsandMarkets™, the market is projected to reach USD 175 million by 2024 from USD 130 million in 2019, at a CAGR of 6.1%
The rising incidence of hospital-acquired infections (HAIs), growth in the pharmaceutical and biotechnology industries, and increasing outsourcing of bio decontamination services are factors driving the growth of the market.
What the global market looks like?
The Global Bio Decontamination Market is segmented on the basis of Product, Agent, Type, End User and Region.
The equipment segment commanded the largest share in 2019.
On the basis of product & service, the Bio Decontamination Market is segmented into equipment, consumables, and services. In 2018, the equipment segment accounted for the largest market share of market. The launch of new and advanced instruments, portability, and the reduced need for manual intervention are key factors driving the growth of this segment.
Chamber decontamination held the largest share of the Bio Decontamination Market in 2019.
By type, the market is segmented into room and chamber bio decontamination. In 2018, chambers accounted for the largest share of the market. The large share of this segment can be attributed to factors such as lower power consumption, smaller footprint, and cost-effectiveness.
Hydrogen Peroxide to dominate the Bio Decontamination Market in 2019.
On the basis of agent type, the market is segmented into hydrogen peroxide, nitrogen dioxide, chlorine dioxide, and peracetic acid. In 2018, the hydrogen peroxide segment accounted for the largest share of the market. The advantages offered by hydrogen peroxide, such as material compatibility and safety with minimum residue, are the major factors contributing to its dominance in the market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=104696777
Geographical Analysis Of Market:
North America commanded the largest share of the Bio Decontamination Market in 2019.
On the basis of region, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2018, North America commanded the largest share of the Bio Decontamination Market. The large share of this regional segment can be attributed to the growing demand for bio decontamination technologies from the healthcare industry to minimize the occurrence of hospital-acquired infections and the presence of major players in the region.
Key Players and Strategies Adopted by Them:
The major players operating in this market are STERIS (US), Ecolab, Inc. (US), TOMI Environmental Solutions, Inc (US), JCE Biotechnology (France), Fedegari Autoclavi SpA (Italy), Zhejiang Tailin Bioengineering Co., Ltd. (China), Noxilizer, Inc. (US), Howorth Air Technology Limited (UK), Wenzhou Weike Biological Laboratory Equipment Co., Ltd. (China), ClorDiSys Solutions Inc. (US), and Amira S.r.l. (Italy).
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=104696777
Bio Decontamination Market - Trends Estimates High Demand by 2024
With a fixated viewpoint concerning the global aptamer market, it is examined that application benefits are currently restricted to the pharmaceutical industry.
However, intense research & development initiatives carried out by leading players active in the aptamer market are likely to widen existing usage of these neoteric molecules, thereby creating smooth market opportunities.The business intelligence study of the aptamer market covers the estimation size of the market both in terms of value and volume.
In a bid to recognize the growth prospects in the aptamer market, the market study has been geographically fragmented into important regions that are progressing faster than the overall market.
Each segment of the aptamer market has been individually analyzed on the basis of pricing, distribution, and demand prospect for the following regions:North America (Canada, US)Latin America (Argentina, Mexico)Europe (NORDIC, UK)APEJ (China, India)Get Customize Sample Copy of Report from Here - https://www.factmr.com/connectus/sample?flag=S_id=173According to research findings, the application of aptamers are likely to expand across the food and beverage industry as biosensors so as to ensure the quality of products.
Looking at all such favorable influences, it is assessed that the global aptamer market is anticipated to progress at an inspiring CAGR growth rate of 21% during the forecast period (2020-2025).Concentrated Research Actions in North America Set to Motivate Aptamer Market GrowthPresently, North America enjoys its lead in the aptamer market which is powered by the early-bird’s advantage of progressive technology that manufacturers are unloading in the region.
It should be noted that, continuous development in the research & development of therapeutics as well as diagnostics equipment commenced by research institutes is likely to escalate demand for aptamers.
Rising geriatric population, growing prevalence of chronic diseases, increasing number of diagnostic centers, and increasing physician awareness & demand for histopathology are expected to fuel the growth of this market in the coming years.
However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine offer significant growth opportunities in the immunohistochemistry market.The immunohistochemistry market is projected to reach USD 2.12 billion by 2021, at a CAGR of 7.3% during the forecast period.
Antibodies segment to dominate the global immunohistochemistry marketBased on products, the market is segmented into antibodies, reagents, kits, and equipment.
In 2015, the antibodies segment accounted for the largest share of the global immunohistochemistry market.
The rising adoption of high-throughput assays, such as array comparative genomic hybridization, cDNA microarray, next-generation sequencing techniques, and histological tests, have led to the rapid discovery of thousands of potential antibodies.Diagnostics segment accounted for largest share of immunohistochemistry marketImmunohistochemistry market is categorized into two application segments, namely, diagnostics and drug testing.
The global market for diagnostic applications is further segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, autoimmune diseases, and nephrological diseases.
According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability.
Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of pneumonia, as well as observed in patients suffering from the novel coronavirus (COVID-19).
To order this 235+ page report, which features 95+ figures and 110+ tables, please visit this link The USD 1.1 billion (by 2030) financial opportunity within the handheld ultrasound imaging devices market has been analyzed across the following segments:Application AreaCardiac ScanningEmergency MedicinesGynecological / Obstetrics ScanningMusculoskeletal ScanningPulmonary ScanningUrological ScanningVascular SurgeryOther Application Areas Type of Transducer ArrayCurvedEndocavityLinearPhasedOther Scanners Type of SoftwareSmartphone ApplicationsCustomized Software End-UsersAmbulatory Surgical CentersDiagnostic Imaging CentersHospitalsMaternity ClinicsSpecialty ClinicsOther End-Users Key Geographical Regions North AmericaEuropeAsia-Pacific and the Rest of the World The Global Handheld Ultrasound Imaging Devices Market, 2020-2030, report features the following companies, which we identified to be key players in this domain: Aidmax MedicalBeijing Konted Medical TechnologyBiim UltrasoundBreastITButterfly NetworkCJ MedicalClarius Mobile HealthEchoNousFujifilmGE HealthcareGuangzhou Top Medical EquipmentHealcerionInterson Medical InstrumentsPhilipsSomax SystemsVINNOWuHan Youkey Bio-Medical ElectronicsYor Labs Table of Contents Preface 2.
Executive Summary Introduction Market Landscape Company Profiles Brand Positioning Analysis of Key Players Partnerships and Collaborations Cost Saving Analysis Demand Analysis Market Forecast End-User Specific Opportunity Analysis Case Study: Impact of Coronavirus Outbreak Conclusion Executive Insights Appendix 1: Tabulated Data Appendix 2: List of Companies and Organizations To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html Contact DetailsGaurav Chaudhary+1 (415) 800 [email protected]
According MarketsandMarkets Research – The Rat Model Market is expected to reach USD 588.9 million, at a CAGR of 8.7%.Application of Rat Model in Detailed:Rat model applications in various therapeutic indications such as toxicology, oncology, diabetes, neurology, immunology and infectious diseases, and others (rare disease, cardiovascular, metabolic disease, hematopoiesis, and regenerative medicines) coupled with the increase in R activities carried out by pharmaceutical and biotechnology companies drive the growth of rat model marketDIABETES:Rats are considered to be excellent experimental models for understanding the complex genetic basis of diseases such as diabetes.
However, it is quite difficult to carry out research studies in human beings, owing to problems such as genetic heterogeneity and lack of controlled lifestyles.
Rat models act as suitable models to study specific genetic mutations and to understand the function of genes on a homogeneous genetic background.Browse 132 market data tables and 47 figures spread through 253 pages and in-depth TOC | Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=76036494Market Segmentation in Depth:On the basis of type, the rat model market is segmented into outbred rats, inbred rats, knockout/genetically engineered rats, hybrid/congenic rats, conditioned/surgically modified rats, and immunodeficient rats model.
Knockout/genetically engineered rats segment is expected to grow at the highest CAGR during the forecast period.
The high growth rate of knockout/genetically engineered rats segment can be attributed to the use of this type of rat model to carry out researches on disease such as oncology, obesity, heart disease, diabetes, arthritis, drug abuse, anxiety, aging, and Parkinson’s.On the basis of services, the rat model market is segmented into breeding, cryopreservation, quarantine, rederivation, model in-licensing, genetic testing, and others such as surgical services, line rescue services, and in vivo pharmacology services.
The cryopreservation segment is estimated grow at the highest CAGR during the forecast period, as this segment help in obtaining the genetic material of rats even after the reproductive lifespan of these rats is over.
With a fixated viewpoint concerning the global aptamer market, it is examined that application benefits are currently restricted to the pharmaceutical industry.
However, intense research & development initiatives carried out by leading players active in the aptamer market are likely to widen existing usage of these neoteric molecules, thereby creating smooth market opportunities.The business intelligence study of the aptamer market covers the estimation size of the market both in terms of value and volume.
In a bid to recognize the growth prospects in the aptamer market, the market study has been geographically fragmented into important regions that are progressing faster than the overall market.
Each segment of the aptamer market has been individually analyzed on the basis of pricing, distribution, and demand prospect for the following regions:North America (Canada, US)Latin America (Argentina, Mexico)Europe (NORDIC, UK)APEJ (China, India)Get Customize Sample Copy of Report from Here - https://www.factmr.com/connectus/sample?flag=S_id=173According to research findings, the application of aptamers are likely to expand across the food and beverage industry as biosensors so as to ensure the quality of products.
Looking at all such favorable influences, it is assessed that the global aptamer market is anticipated to progress at an inspiring CAGR growth rate of 21% during the forecast period (2020-2025).Concentrated Research Actions in North America Set to Motivate Aptamer Market GrowthPresently, North America enjoys its lead in the aptamer market which is powered by the early-bird’s advantage of progressive technology that manufacturers are unloading in the region.
It should be noted that, continuous development in the research & development of therapeutics as well as diagnostics equipment commenced by research institutes is likely to escalate demand for aptamers.
According MarketsandMarkets Research – The Rat Model Market is expected to reach USD 588.9 million, at a CAGR of 8.7%.Application of Rat Model in Detailed:Rat model applications in various therapeutic indications such as toxicology, oncology, diabetes, neurology, immunology and infectious diseases, and others (rare disease, cardiovascular, metabolic disease, hematopoiesis, and regenerative medicines) coupled with the increase in R activities carried out by pharmaceutical and biotechnology companies drive the growth of rat model marketDIABETES:Rats are considered to be excellent experimental models for understanding the complex genetic basis of diseases such as diabetes.
However, it is quite difficult to carry out research studies in human beings, owing to problems such as genetic heterogeneity and lack of controlled lifestyles.
Rat models act as suitable models to study specific genetic mutations and to understand the function of genes on a homogeneous genetic background.Browse 132 market data tables and 47 figures spread through 253 pages and in-depth TOC | Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=76036494Market Segmentation in Depth:On the basis of type, the rat model market is segmented into outbred rats, inbred rats, knockout/genetically engineered rats, hybrid/congenic rats, conditioned/surgically modified rats, and immunodeficient rats model.
Knockout/genetically engineered rats segment is expected to grow at the highest CAGR during the forecast period.
The high growth rate of knockout/genetically engineered rats segment can be attributed to the use of this type of rat model to carry out researches on disease such as oncology, obesity, heart disease, diabetes, arthritis, drug abuse, anxiety, aging, and Parkinson’s.On the basis of services, the rat model market is segmented into breeding, cryopreservation, quarantine, rederivation, model in-licensing, genetic testing, and others such as surgical services, line rescue services, and in vivo pharmacology services.
The cryopreservation segment is estimated grow at the highest CAGR during the forecast period, as this segment help in obtaining the genetic material of rats even after the reproductive lifespan of these rats is over.
Rising geriatric population, growing prevalence of chronic diseases, increasing number of diagnostic centers, and increasing physician awareness & demand for histopathology are expected to fuel the growth of this market in the coming years.
However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine offer significant growth opportunities in the immunohistochemistry market.The immunohistochemistry market is projected to reach USD 2.12 billion by 2021, at a CAGR of 7.3% during the forecast period.
Antibodies segment to dominate the global immunohistochemistry marketBased on products, the market is segmented into antibodies, reagents, kits, and equipment.
In 2015, the antibodies segment accounted for the largest share of the global immunohistochemistry market.
The rising adoption of high-throughput assays, such as array comparative genomic hybridization, cDNA microarray, next-generation sequencing techniques, and histological tests, have led to the rapid discovery of thousands of potential antibodies.Diagnostics segment accounted for largest share of immunohistochemistry marketImmunohistochemistry market is categorized into two application segments, namely, diagnostics and drug testing.
The global market for diagnostic applications is further segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, autoimmune diseases, and nephrological diseases.
According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability.
Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of pneumonia, as well as observed in patients suffering from the novel coronavirus (COVID-19).
To order this 235+ page report, which features 95+ figures and 110+ tables, please visit this link The USD 1.1 billion (by 2030) financial opportunity within the handheld ultrasound imaging devices market has been analyzed across the following segments:Application AreaCardiac ScanningEmergency MedicinesGynecological / Obstetrics ScanningMusculoskeletal ScanningPulmonary ScanningUrological ScanningVascular SurgeryOther Application Areas Type of Transducer ArrayCurvedEndocavityLinearPhasedOther Scanners Type of SoftwareSmartphone ApplicationsCustomized Software End-UsersAmbulatory Surgical CentersDiagnostic Imaging CentersHospitalsMaternity ClinicsSpecialty ClinicsOther End-Users Key Geographical Regions North AmericaEuropeAsia-Pacific and the Rest of the World The Global Handheld Ultrasound Imaging Devices Market, 2020-2030, report features the following companies, which we identified to be key players in this domain: Aidmax MedicalBeijing Konted Medical TechnologyBiim UltrasoundBreastITButterfly NetworkCJ MedicalClarius Mobile HealthEchoNousFujifilmGE HealthcareGuangzhou Top Medical EquipmentHealcerionInterson Medical InstrumentsPhilipsSomax SystemsVINNOWuHan Youkey Bio-Medical ElectronicsYor Labs Table of Contents Preface 2.
Executive Summary Introduction Market Landscape Company Profiles Brand Positioning Analysis of Key Players Partnerships and Collaborations Cost Saving Analysis Demand Analysis Market Forecast End-User Specific Opportunity Analysis Case Study: Impact of Coronavirus Outbreak Conclusion Executive Insights Appendix 1: Tabulated Data Appendix 2: List of Companies and Organizations To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html Contact DetailsGaurav Chaudhary+1 (415) 800 [email protected]